Bilateral kidney ligation abolishes pressor response to N(G)-nitro-D-arginine

European Journal of Pharmacology

Volumn 366, Issue 2-3, 1999, Pages 175-179

  Wang, Yong Xiang ^a   Cheng, Xing ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

(Ex vivo); (In vivo); Chiral inversion; N(G) Nitro D arginine; N(G) Nitro L arginine; Nitric oxide (NO)

Indexed keywords

N(G) NITRO DEXTRO ARGININE; N(G) NITROARGININE; NITRIC OXIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIRALITY; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIGATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ARGININE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; KIDNEY; LIGATION; MUSCLE CONTRACTION; MUSCLE RELAXATION; NITROARGININE; NOREPINEPHRINE; PHENYLEPHRINE; RATS; RENAL ARTERY; RENAL VEINS; STEREOISOMERISM; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0033062772     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00906-6     Document Type: Article

References (22)

1. G-nitro-D-arginine by kidney homogenate. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;495-499.
2. Drummond L., Caldwell J., Wilson H.K. The stereoselectivity of 1,2-phenylethanediol and mandelic acid metabolism and disposition in the rat. Xenobiotica. 20:1990;159-168.
3. Gardiner S.M., Compton A.M., Bennett T., Palmer R.M.J., Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 15:1990;486-492.
4. G-nitro-L-arginine methyl ester in conscious Long Evans rats. Br. J. Pharmacol. 101:1990;625-631.
5. G-nitro-arginine. Br. J. Pharmacol. 102:1991;565-566.
6. Hutt A.J., Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids - a novel route with pharmacological consequences. J. Pharm. Pharmacol. 35:1983;693-704.
7. King J.N., Mauron C., LeGoff C., Hauffe S. Bidirectional chiral inversion of the enantiomers of the nonsteroidal antiinflammatory drug oxindanac in dogs. Chirality. 6:1994;460-466.
8. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
9. G-nitro-L-arginine (N5-[imino (nitroamino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;143-147.
10. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153:1988;1251-1256.
11. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci., USA. 86:1989;3375-3378.
12. Rees D.D., Palmer R.M.J., Hodson H.F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96:1989;418-424.
13. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
14. Raszkiewicz J.L., Linville D.G., Kerwin J.F. Jr., Wagenaar F., Arneric S.P. Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. J. Neurosci. Res. 33:1992;129-135.
15. Sanins S.M., Adams W.J., Kaiser D.G., Halstead G.W., Hosley J., Barnes H., Baillie T.A. Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metab. Dispos. 19:1991;405-410.
16. Walters R.R., Hsu C.Y. Chiral assay methods for lifibrol and metabolites in plasma and the observation of unidirectional chiral inversion following administration of the enantiomers to dogs. Chirality. 6:1994;105-115.
17. G-nitro-L-arginine in pentobarbital-anesthetized rats. Life Sci. 47:1990;2217-2224.
18. G-nitro-arginine on blood pressure in pentobarbital-anaesthetized rats. Pharmacology (Life Sci. Adv.). 9:1990;723-728.
19. Wang Y.X., Pang C.C.Y. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J. Pharmacol. Exp. Ther. 265:1993;263-272.
20. G-nitro-arginine in conscious rats are antagonized by L- but not D-arginine. Eur. J. Pharmacol. 200:1991;77-81.
21. G-nitro-arginine methyl ester (NAME). Can. Fed. Biol. Soc. 35:1992;80.
22. G-nitro-arginine on endothelium-dependent relaxation of rat aorta. J. Pharmacol. Exp. Ther. 265:1993;112-119.